Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention


  Free Subscription

Articles published in Neurosci Lett

Retrieve available abstracts of 27 articles:
HTML format

Single Articles

    November 2022
  1. GORNEROVA N, Brunovsky M, Klirova M, Novak T, et al
    The effect of Low-Frequency rTMS on Auditory Hallucinations, EEG Source Localization and Functional Connectivity in Schizophrenia.
    Neurosci Lett. 2022 Nov 22:136977. doi: 10.1016/j.neulet.2022.136977.
    PubMed     Abstract available

    October 2022
  2. PAN B, Xu L, Weng J, Wang Y, et al
    Effects of icariin on alleviating schizophrenia-like symptoms by regulating the miR-144-3p/ATP1B2/mTOR signalling pathway.
    Neurosci Lett. 2022 Oct 16:136918. doi: 10.1016/j.neulet.2022.136918.
    PubMed     Abstract available

    August 2022
  3. LIN C, Gou M, Pan S, Tong J, et al
    Serum hyperhomocysteine and cognitive impairment in first-episode patients with schizophrenia: moderated by brain cortical thickness.
    Neurosci Lett. 2022 Aug 6:136826. doi: 10.1016/j.neulet.2022.136826.
    PubMed     Abstract available

    July 2022
  4. LIU C, Xu X, Liu X, Zhang T, et al
    DRD3 Ser9Gly polymorphism and treatment response to antipsychotics in schizophrenia: A meta-analysis.
    Neurosci Lett. 2022;786:136788.
    PubMed     Abstract available

    June 2022
  5. RIEL H, MacPhee C, Rudolph ED, Tibbo PG, et al
    MMN and P3a elicited by a novelty paradigm in healthy controls: An investigation of sex differences.
    Neurosci Lett. 2022;781:136654.
    PubMed     Abstract available

    May 2022
  6. REN J, Chen Y, Fang X, Wang D, et al
    Correlation of Orexin-A and brain-derived neurotrophic factor levels in metabolic syndrome and cognitive impairment in schizophrenia treated with clozapine.
    Neurosci Lett. 2022 May 23:136695. doi: 10.1016/j.neulet.2022.136695.
    PubMed     Abstract available

  7. ZHANG M, Hong X, Yang F, Fan H, et al
    Structural brain imaging abnormalities correlate with positive symptom in schizophrenia.
    Neurosci Lett. 2022 May 17:136683. doi: 10.1016/j.neulet.2022.136683.
    PubMed     Abstract available

    March 2022
  8. LI N, Huang J, Zhang P, Tong J, et al
    Dysfunctional monocytic toll-like receptor 4 signaling pathway and cognitive deficits in chronic schizophrenia patients with tardive dyskinesia.
    Neurosci Lett. 2022 Mar 22:136581. doi: 10.1016/j.neulet.2022.136581.
    PubMed     Abstract available

    February 2022
  9. CHENG P, Zhang R, Shan S, Yuan B, et al
    Novel IL1RAP mutation associated with schizophrenia interferes with neuronal growth and related NF-kappaB signal pathways.
    Neurosci Lett. 2022 Feb 15:136533. doi: 10.1016/j.neulet.2022.136533.
    PubMed     Abstract available

    December 2021
  10. SMUCNY J, Carter CS, Maddock RJ
    Magnetic resonance spectroscopic evidence of increased choline in the dorsolateral prefrontal and visual cortices in recent onset schizophrenia.
    Neurosci Lett. 2021;770:136410.
    PubMed     Abstract available

  11. YAN P, Gao B, Wang S, Wang S, et al
    Association of 5-HTR2A T102C and A-1438G polymorphisms with clinical response to atypical antipsychotic treatment in schizophrenia: A meta-analysis.
    Neurosci Lett. 2021;770:136395.
    PubMed     Abstract available

  12. LIU L, Hu Y, Lu Y, Hu L, et al
    Sex-dependent DNA hypermethylation of SLC6A4 in patients with schizophrenia.
    Neurosci Lett. 2021;769:136394.
    PubMed     Abstract available

    November 2021
  13. AZIMI SANAVI M, Ghazvini H, Ghalehnoei H, Zargari M, et al
    Effects of Clozapine and Risperidone Antipsychotic Drugs on the Expression of CACNA1C and Behavioral Changes in Rat 'Ketamine Model of Schizophrenia.
    Neurosci Lett. 2021 Nov 18:136354. doi: 10.1016/j.neulet.2021.136354.
    PubMed     Abstract available

    October 2021
  14. JUNG HY, Jung S, Bang M, Choi TK, et al
    White matter correlates of impulsivity in frontal lobe and their associations with treatment response in first-episode schizophrenia.
    Neurosci Lett. 2021 Oct 28:136309. doi: 10.1016/j.neulet.2021.136309.
    PubMed     Abstract available

    September 2021
  15. MOGHADDAM AH, Maboudi K, Bavaghar B, Sangdehi SRM, et al
    Neuroprotective effects of curcumin-loaded nanophytosome on ketamine-induced schizophrenia-like behaviors and oxidative damage in male mice.
    Neurosci Lett. 2021;765:136249.
    PubMed     Abstract available

  16. KURIMOTO E, Yamada R, Hirakawa T, Kimura H, et al
    Therapeutic Potential of TAK-071, a Muscarinic M1 Receptor Positive Allosteric Modulator with Low Cooperativity, For the Treatment of Cognitive Deficits and Negative Symptoms Associated with Schizophrenia.
    Neurosci Lett. 2021 Sep 9:136240. doi: 10.1016/j.neulet.2021.136240.
    PubMed     Abstract available

    July 2021
  17. MAREDIA M, Hamilton J, Thanos PK
    A high-fat diet, but not haloperidol or olanzapine administration, increases activated microglial expression in the rat brain.
    Neurosci Lett. 2021;757:135976.
    PubMed     Abstract available

  18. VALES K, Holubova K
    Minireview: Animal model of schizophrenia from the perspective of behavioral pharmacology: effect of treatment on cognitive functions.
    Neurosci Lett. 2021 Jul 2:136098. doi: 10.1016/j.neulet.2021.136098.
    PubMed     Abstract available

    June 2021
  19. RAMPINO A, Annese T, Torretta S, Tamma R, et al
    Involvement of Vascular Endothelial Growth Factor in schizophrenia.
    Neurosci Lett. 2021 Jun 30:136093. doi: 10.1016/j.neulet.2021.136093.
    PubMed     Abstract available

  20. ZHANG Q, He H, Cao B, Gao R, et al
    Analysis of cognitive impairment in schizophrenia based on machine learning: Interaction between psychological stress and immune system.
    Neurosci Lett. 2021;760:136084.
    PubMed     Abstract available

    The endocannabinoid system as a therapeutic target for schizophrenia: failures and potentials.
    Neurosci Lett. 2021 Jun 16:136064. doi: 10.1016/j.neulet.2021.136064.
    PubMed     Abstract available

  22. PATRIK S, Filip S
    Brain ventricular volume changes in schizophrenia. A narrative review.
    Neurosci Lett. 2021 Jun 16:136065. doi: 10.1016/j.neulet.2021.136065.
    PubMed     Abstract available

  23. ANDROVICOVA R, Pfaus JG, Ovsepian SV
    Estrogen Pendulum in Schizophrenia and Alzheimer's Disease: Review of Therapeutic Benefits and Outstanding Questions.
    Neurosci Lett. 2021 Jun 8:136038. doi: 10.1016/j.neulet.2021.136038.
    PubMed     Abstract available

  24. KOLAR D, Kleteckova L, Brozka H, Vales K, et al
    Mini-Review: Brain Energy Metabolism and its Role in Animal Models of Depression, Bipolar Disorder, Schizophrenia and Autism.
    Neurosci Lett. 2021 Jun 4:136003. doi: 10.1016/j.neulet.2021.136003.
    PubMed     Abstract available

    April 2021
  25. MEIRON O, David J, Yaniv A
    Left prefrontal transcranial direct-current stimulation reduces symptom-severity and acutely enhances working memory in schizophrenia.
    Neurosci Lett. 2021;755:135912.
    PubMed     Abstract available

    January 2021
  26. CAI Y, Xing L, Yang T, Chai R, et al
    The neurodevelopmental role of dopaminergic signaling in neurological disorders.
    Neurosci Lett. 2021;741:135540.
    PubMed     Abstract available

    February 2020
  27. CALABRO M, Porcelli S, Crisafulli C, Albani D, et al
    Genetic variants associated with psychotic symptoms across psychiatric disorders.
    Neurosci Lett. 2020;720:134754.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Schizophrenia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.